#CNBC Dr. Scott Gottlieb: Tariffs are a very inefficient tool to reshore drug manufacturing

Dr. Scott Gottlieb: Tariffs are a very inefficient tool to reshore drug manufacturing
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of SCOTUS tariff ruling on the pharmaceutical industry, news of Novo Nordisk’s weight loss drug failing to match Eli Lilly’s in trial, and more.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”